Deal could net $100m for Seventh day Adventist’s Sanitarium

Food giant Sanitarium, the tax-exempt manufacturer of Weet-Bix and Marmite, is expected to reap significant financial returns from the sale of a United States-based drug developer’s intellectual property to a Nasdaq-listed pharmaceutical firm.

The deal could net Asklepion Pharmaceuticals – reportedly controlled by Sanitarium’s shareholder, the Seventh day Adventist Church – more than $100 million over the next few years, plus royalties. Continue reading

Additional reading

News category: New Zealand, News Shorts.

Tags: ,